Advance Zinctek Limited has released a press release.
Zinc Oxide 100% exempt from Pharmaceutical Tariifs
Earlier from Advance Zinctek
- Appendix 4D
- Chair's Presentation to Shareholders
- Improvement of 26.83% in First Quarter Revenue - FY26
- Appendix 4E
Advance Zinctek Limited has released a press release.